Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword

SIMPLE SUMMARY: Immunotherapy has a rapidly expanding role for the treatment of several cancers due to durable clinical activity and favorable tolerability. However, the unique biology of thymic epithelial tumors (TETs) increases the risk of immune-mediated toxicity. In this paper we review the biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballman, Madison, Zhao, Chen, McAdams, Meredith J., Rajan, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105984/
https://www.ncbi.nlm.nih.gov/pubmed/35565190
http://dx.doi.org/10.3390/cancers14092060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105984/
https://www.ncbi.nlm.nih.gov/pubmed/35565190
http://dx.doi.org/10.3390/cancers14092060

Ejemplares similares